Literature DB >> 11102343

Olanzapine and pancreatitis.

R Hagger, C Brown, P Hurley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11102343     DOI： 10.1192/bjp.177.6.567

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  7 in total

Review 1.  Switching between second-generation antipsychotics: why and how?

Authors:  Monika Edlinger; Susanne Baumgartner; Nadja Eltanaihi-Furtmüller; Martina Hummer; W Wolfgang Fleischhacker
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 2.  Pharmacotherapy of alcoholism in patients with co-morbid psychiatric disorders.

Authors:  Benjamin I Goldstein; Artemis Diamantouros; Ayal Schaffer; Claudio A Naranjo
Journal:  Drugs       Date:  2006       Impact factor: 9.546

3.  Pancreatitis and diabetic ketoacidosis with quetiapine use.

Authors:  Javaid Rashid; Perry J Starer; Shazia Javaid
Journal:  Psychiatry (Edgmont)       Date:  2009-05

4.  Pancreatitis following Olanzapine Therapy: A Report of Three Cases.

Authors:  Thomas A Kerr; Sreenivasa Jonnalagadda; Chandra Prakash; Riad Azar
Journal:  Case Rep Gastroenterol       Date:  2007-06-22

5.  Successful clozapine rechallenge following recurrent clozapine-associated pancreatitis: a case report.

Authors:  Victoria Rodriguez; Kieran Hanley; Ana Julia Arias; Diego Quattrone; Joseph Kuforiji; Eromona Whiskey; Sukhi S Shergill
Journal:  BMC Pharmacol Toxicol       Date:  2020-05-20       Impact factor: 2.483

Review 6.  Analysis of the clinical characteristics of olanzapine-induced acute pancreatitis.

Authors:  Yang He; Weijin Fang; Zuojun Li; Linli Sun; Yulu Zhou; Cuifang Wu; Wei Sun; Chunjiang Wang
Journal:  Ther Adv Psychopharmacol       Date:  2022-04-29

7.  Antidopaminergic drugs and acute pancreatitis: a population-based study.

Authors:  Robert Bodén; Tomas S Bexelius; Fredrik Mattsson; Jesper Lagergren; Mats Lindblad; Rickard Ljung
Journal:  BMJ Open       Date:  2012-05-11       Impact factor: 2.692
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.